{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:40:40Z","timestamp":1791308440068,"version":"4.3.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100007279","name":"Shanghai Municipal Health Bureau","doi-asserted-by":"crossref","award":["2009206"],"award-info":[{"award-number":["2009206"]}],"id":[{"id":"10.13039\/501100007279","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["30973462"],"award-info":[{"award-number":["30973462"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["11QA1403700"],"award-info":[{"award-number":["11QA1403700"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.cca.2015.08.005","type":"journal-article","created":{"date-parts":[[2015,8,11]],"date-time":"2015-08-11T04:38:49Z","timestamp":1439267929000},"page":"115-120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Salivary uric acid as a noninvasive biomarker for monitoring the efficacy of urate-lowering therapy in a patient with chronic gouty arthropathy"],"prefix":"10.1016","volume":"450","author":[{"given":"Jianxing","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2015.08.005_bb0005","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1080\/15257770.2011.596496","article-title":"Japanese guideline for the management of hyperuricemia and gout: second edition","volume":"30","author":"Yamanaka","year":"2011","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"10.1016\/j.cca.2015.08.005_bb0010","doi-asserted-by":"crossref","first-page":"14351","DOI":"10.1073\/pnas.1001072107","article-title":"Treating gout with pegloticase, a PEGylated urate oxidase, provides insight into the importance of uric acid as an antioxidant in vivo","volume":"107","author":"Hershfield","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cca.2015.08.005_bb0015","doi-asserted-by":"crossref","first-page":"919","DOI":"10.3949\/ccjm.77a.09080","article-title":"Managing gout: how is it different in patients with chronic kidney disease?","volume":"77","author":"El-Zawawy","year":"2010","journal-title":"Cleve. Clin. J. Med."},{"key":"10.1016\/j.cca.2015.08.005_bb0020","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/ar3199","article-title":"Epidemiology of gout","volume":"12","author":"Roddy","year":"2010","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.cca.2015.08.005_bb0025","first-page":"549","article-title":"Gout\u2014current diagnosis and treatment","volume":"106","author":"Tausche","year":"2009","journal-title":"Dtsch. Arztebl. Int."},{"key":"10.1016\/j.cca.2015.08.005_bb0030","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/ndt\/gfl538","volume":"22","author":"Athyros","year":"2007","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.cca.2015.08.005_bb0035","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.amjcard.2008.05.019","article-title":"Association between serum uric acid and perioperative and late cardiovascular outcome in patients with suspected or definite coronary artery disease undergoing elective vascular surgery","volume":"102","author":"Dunkelgrun","year":"2008","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.cca.2015.08.005_bb0040","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.cca.2014.12.030","article-title":"Lipoprotein subfractions partly mediate the association between serum uric acid and coronary artery disease","volume":"441","author":"Zhang","year":"2015","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2015.08.005_bb0045","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s11926-015-0495-2","article-title":"Hyperuricemia, gout, and cardiovascular disease: an update","volume":"17","author":"Abeles","year":"2015","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.cca.2015.08.005_bb0050","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1161\/01.STR.0000221716.55088.d4","article-title":"Uric acid is a risk factor for myocardial infarction and stroke: the Rotterdam study","volume":"37","author":"Bos","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.cca.2015.08.005_bb0055","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/art.24612","article-title":"Hyperuricemia and risk of stroke: a systematic review and meta-analysis","volume":"61","author":"Kim","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cca.2015.08.005_bb0060","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1758-5996-4-14","article-title":"Salivary uric acid as a noninvasive biomarker of metabolic syndrome","volume":"4","author":"Soukup","year":"2012","journal-title":"Diabetol. Metab. Syndr."},{"key":"10.1016\/j.cca.2015.08.005_bb0065","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1136\/ard.2007.083071","article-title":"Efficacy and tolerability of urate-lowering drugs in gout: a randomised controlled trial of benzbromarone versus probenecid after failure of allopurinol","volume":"68","author":"Reinders","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cca.2015.08.005_bb0070","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1136\/ard.2006.055269","article-title":"EULAR evidence based recommendations for gout. Part II: management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)","volume":"65","author":"Zhang","year":"2006","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cca.2015.08.005_bb0075","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/art.10511","article-title":"Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout","volume":"47","author":"Perez-Ruiz","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cca.2015.08.005_bb0080","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/art.20405","article-title":"A retrospective study of the relationship between serum urate level and recurrent attacks of gouty arthritis: evidence for reduction of recurrent gouty arthritis with antihyperuricemic therapy","volume":"51","author":"Shoji","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cca.2015.08.005_bb0085","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1056\/NEJMoa050373","article-title":"Febuxostat compared with allopurinol in patients with hyperuricemia and gout","volume":"353","author":"Becker","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cca.2015.08.005_bb0090","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1136\/ard.57.9.545","article-title":"Efficacy of allopurinol and benzbromarone for the control of hyperuricaemia. A pathogenic approach to the treatment of primary chronic gout","volume":"57","author":"Perez-Ruiz","year":"1998","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cca.2015.08.005_bb0095","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.cca.2014.05.009","article-title":"S100A8 as potential salivary biomarker of oral squamous cell carcinoma using nanoLC\u2013MS\/MS","volume":"436","author":"Jou","year":"2014","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2015.08.005_bb0100","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.cca.2014.08.027","article-title":"Organic anion composition of human whole saliva as determined by ion chromatography","volume":"438","author":"Chen","year":"2015","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2015.08.005_bb0105","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.cca.2014.01.006","article-title":"Determination of acetone in saliva by reversed-phase liquid chromatography with fluorescence detection and the monitoring of diabetes mellitus patients with ketoacidosis","volume":"430","author":"Fujii","year":"2014","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2015.08.005_bb0110","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.cca.2011.04.004","article-title":"Salivary zinc finger protein 510 peptide as a novel biomarker for detection of oral squamous cell carcinoma in early stages","volume":"412","author":"Jou","year":"2011","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2015.08.005_bb0115","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.cca.2015.02.045","article-title":"Salivary, blood and plasma nitrite concentrations in periodontal patients and healthy individuals before and after periodontal treatment","volume":"444","author":"Meschiari","year":"2015","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2015.08.005_bb0120","first-page":"124","article-title":"Saliva\u2014a diagnostic window to the body, both in health and in disease","volume":"2","author":"Greabu","year":"2009","journal-title":"J. Med. Life"},{"key":"10.1016\/j.cca.2015.08.005_bb0125","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3109\/08860227809079326","article-title":"Correlation of biochemical parameters in serum and saliva in chronic azotemic patients and patients on chronic hemodialysis","volume":"2","author":"Goll","year":"1978","journal-title":"J. Dial."},{"key":"10.1016\/j.cca.2015.08.005_bb0130","first-page":"1295","article-title":"Is it time to revise the normal range of serum uric acid levels?","volume":"18","author":"Desideri","year":"2014","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.cca.2015.08.005_bb0140","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1093\/rheumatology\/keg362","article-title":"Salivary gland involvement in rheumatoid arthritis and its relationship to induced oxidative stress","volume":"42","author":"Nagler","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.cca.2015.08.005_bb0145","first-page":"1171","article-title":"Clinical significance of saliva urea, creatinine, and uric acid levels in patients with chronic kidney disease","volume":"37","author":"Xia","year":"2012","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"key":"10.1016\/j.cca.2015.08.005_bb0150","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1744-9987.2008.00564.x","article-title":"Compositional and oxidative analysis in the saliva and serum of predialysis chronic kidney disease patients and end-stage renal failure patients on peritoneal dialysis","volume":"12","author":"Bibi","year":"2008","journal-title":"Ther. Apher. Dial."},{"key":"10.1016\/j.cca.2015.08.005_bb0155","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1055\/s-0030-1255107","article-title":"Blood and salivary oxidative stress biomarkers following an acute session of resistance exercise in humans","volume":"31","author":"Deminice","year":"2010","journal-title":"Int. J. Sports Med."},{"key":"10.1016\/j.cca.2015.08.005_bb0160","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.jchromb.2010.01.006","article-title":"Optimization of Zn2+-containing mobile phase for simultaneous determination of kynurenine, kynurenic acid and tryptophan in human plasma by high performance liquid chromatography","volume":"878","author":"Zhao","year":"2010","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.cca.2015.08.005_bb0165","doi-asserted-by":"crossref","first-page":"648","DOI":"10.3109\/0886022X.2013.790301","article-title":"Plasma kynurenic acid\/tryptophan ratio: a sensitive and reliable biomarker for the assessment of renal function","volume":"35","author":"Zhao","year":"2013","journal-title":"Ren. Fail."},{"key":"10.1016\/j.cca.2015.08.005_bb0170","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1749-6632.1993.tb18343.x","article-title":"Methods for collecting saliva","volume":"694","author":"Navazesh","year":"1993","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.cca.2015.08.005_bb0175","doi-asserted-by":"crossref","first-page":"6781","DOI":"10.1039\/c3ay41061g","article-title":"A simple, rapid and reliable high performance liquid chromatography method for the simultaneous determination of creatinine and uric acid in plasma and urine","volume":"5","author":"Zhao","year":"2013","journal-title":"Anal. Methods"},{"key":"10.1016\/j.cca.2015.08.005_bb0180","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1016\/j.jchromb.2011.07.035","article-title":"Simultaneous determination of urinary tryptophan, tryptophan-related metabolites and creatinine by high performance liquid chromatography with ultraviolet and fluorimetric detection","volume":"879","author":"Zhao","year":"2011","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.cca.2015.08.005_bb0185","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/bmc.3291","article-title":"Simultaneous determination of plasma creatinine, uric acid, kynurenine and tryptophan by high-performance liquid chromatography: method validation and in application to the assessment of renal function","volume":"29","author":"Zhao","year":"2015","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.cca.2015.08.005_bb0190","series-title":"GFR Calculators: Serum Creatinine and Cystatin C","author":"Fadem","year":"2012"},{"key":"10.1016\/j.cca.2015.08.005_bb0195","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0002-9343(84)90743-5","article-title":"Severe allopurinol toxicity. Description and guidelines for prevention in patients with renal insufficiency","volume":"76","author":"Hande","year":"1984","journal-title":"Am. J. Med."},{"key":"10.1016\/j.cca.2015.08.005_bb0200","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/art.1780170207","article-title":"Effect of single oral doses of benzbromarone on serum and urinary uric acid","volume":"17","author":"Jain","year":"1974","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cca.2015.08.005_bb0205","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/art.1780190209","article-title":"Clinical evaluation of benzbromarone: a new uricosuric drug","volume":"19","author":"Sorensen","year":"1976","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cca.2015.08.005_bb0210","doi-asserted-by":"crossref","first-page":"182","DOI":"10.5694\/j.1326-5377.1993.tb137784.x","article-title":"Preventing acute gout when starting allopurinol therapy. Colchicine or NSAIDs?","volume":"159","author":"Kot","year":"1993","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.cca.2015.08.005_bb0215","doi-asserted-by":"crossref","first-page":"179","DOI":"10.7326\/0003-4819-55-2-179","article-title":"Efficacy of colchicine prophylaxis in gout. Prevention of recurrent gouty arthritis over a mean period of five years in 208 gouty subjects","volume":"55","author":"Yu","year":"1961","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.cca.2015.08.005_bb0220","first-page":"437","article-title":"The pharmacology of hypouricemic effect of benzbromarone","volume":"2","author":"Sinclair","year":"1975","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.cca.2015.08.005_bb0225","doi-asserted-by":"crossref","first-page":"283921","DOI":"10.1155\/2015\/283921","article-title":"Age-related responses in circulating markers of redox status in healthy adolescents and adults during the course of a training macrocycle","volume":"2015","author":"Zalavras","year":"2015","journal-title":"Oxid. Med. Cell Longev."},{"key":"10.1016\/j.cca.2015.08.005_bb0230","doi-asserted-by":"crossref","first-page":"e802","DOI":"10.1097\/MD.0000000000000802","article-title":"Association between sex-specific serum uric acid and non-alcoholic fatty liver disease in hinese adults: a large population-based study","volume":"94","author":"Wu","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.cca.2015.08.005_bb0240","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"39","author":"National","year":"2002","journal-title":"Am. J. Kidney Dis."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898115003769?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898115003769?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T02:54:56Z","timestamp":1567047296000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898115003769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":46,"alternative-id":["S0009898115003769"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2015.08.005","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Salivary uric acid as a noninvasive biomarker for monitoring the efficacy of urate-lowering therapy in a patient with chronic gouty arthropathy","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2015.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}